Future trends and possibilities of using induced pluripotent stem cells (iPSC) in regenerative medicine

摘要

Animal testing has shown unsatisfaction when it conies to examination of hepato-neuro-and cardiotoxicity, as well as in the development of new therapies, while use of in vitro model systems is limited by unavailability of human tissues. For this reason, use of human embryonic stem cells (hESC) as unlimited source for producing differentiated somatic progeny, represents a great medical advance. Induced pluripotent stem cells (iPSC) represent a new type of stem cells that occur by reprogramming of genomes of adult stem cells, such as dermal fibroblasts into a pluripotent state. These cells have many similarities with embryonic stem cells, and their reprogramming requests transcription factors OCT4, SOX2, and KLF4. IPSC are characterized by the ability of recovery and differentiation into different cell types such as pancreatic p-cells, hepatocytes, cardiomyocytes, hematopoietic cells, which opens the door to the new methods of treatment of many diseases especially in the field of personalized regenerative medicine. This paperwork contains future trends and possibilities of using iPSC's in regenerative personalized medicine, and with great certainty we can say that the discovery of the same has brought a revolutionary changes to medicine, and that these cells will soon be used not only for modeling of various diseases, but also for treating diseases and finding and testing new drugs that will help to improve the quality of life in many patients.